http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
박봉주,박종철,Hideaki Taguchi,Katsuhiko Kamei,Tetsuhiro Matsuzawa,현성휴 연세대학교의과대학 2011 Yonsei medical journal Vol.52 No.3
Previously, we reported that epigallocatechin 3-O-gallate (EGCg) has growth-inhibitory effect on clinical isolates of Candida species. In this study, we investigated the antifungal activity of EGCg and antifungal agents against thirty-five of dermatophytes clinically isolated by the international guidelines (M38-A2). All isolates exhibited good susceptibility to EGCg (MIC_50, 2-4 μg/mL, MIC_90, 4-8 μg/mL, and geometric mean (GM) MICs, 3.36-4 μg/mL) than those of fluconazole (MIC_50, 2-16 μg/mL, MIC_90, 4-32 μg/mL, and GM MICs, 3.45-25.8 μg/mL) and flucytosin (MIC_50, MIC_90, and GM MICs, >64 μg/mL), although they were less susceptible to other antifungal agents, such as amphotericin B, itraconazole, and miconazole. These activities of EGCg were approximately 4-fold higher than those of fluconazole, and were 4 to 16-fold higher than flucytosin. This result indicates that EGCg can inhibit pathogenic dermatophyte species. Therefore, we suggest that EGCg may be effectively used solely as a possible agent or combined with other antifungal agents for antifungal therapy in dermatophytosis.
한동욱,박종철,임혜련,조한희,Kazuaki Matsumura,백현숙,이미희,우연이,현성휴 한국생체재료학회 2006 생체재료학회지 Vol.10 No.1
The migration of vascular smooth muscle cells (VSMCs) from the tunica media to the subendothelial region is a key event in the development and progression of atherosclerosis and post-angioplasty vascular remodeling. The abnormal growth of VSMC also plays an important role in vascular diseases, including arteriosclerosis and restenosis after angioplasty. Many in vitro assays have shown that ()-epigallocatechin-3-O-gallate (EGCG) has antiproliferative effects on various cells. In this study, the proliferation of rat aortic SMCs (RASMCs) with serum stimulation were investigated into EGCG-loaded collagen matrices (EGCG-CM). Also, the effect of EGCG-CM was examined on the migration of serum-stimulated RASMCs. RASMCs were primarily cultured from rat aorta and then characterized by using immunocytochemical analysis with -smooth muscle actin antibody. EGCG treatment to RASMCs showed a dose-dependent decrease in cell viability as increase in its concentration. EGCG-CM was fabricated by freeze-drying at -40oC and then loaded with EGCG. The proliferation of RASMCs cultured into EGCG-CM was significantly (p < 0.05) attenuated in spite of serum induction (reduction by about 30% after 3 d of cultures and 39% after 5 d). While RASMCs migrated toward CM in response to serum and populated it with essentially uniform ingrowth, EGCG-CM considerably blocked the cell migration after 3 d of incubation. These results suggest that reduction in the proliferation and migration of RASMCs induced by serum may be mediated through the inhibitory effects of EGCG released from CM